Surgical options, such as uvulopalatopharyngoplasty (UPPP) and hypoglossal nerve stimulation, offer alternative pathways, especially for patients who find CPAP intolerable
The companies quoting the numbers are the ones trying to sell you a monthly subscription

GHK-Cu Medicare Advantage Coverage: What You Need to Know in 2026 At a glance Medicare Advantage coverage / not covered under any current MAPD plan FDA approval status / no FDA-approved GHK-Cu drug product exists Average compounded cost / approximately $140 per month from 503A pharmacies Branded product / none on the market as of 2026 Insurance coverage broadly / no commercial or government payer covers GHK-Cu Manufacturer coupon / not applicable (no branded manufacturer) HSA/FSA eligibility / may qualify with a Letter of Medical Necessity Common supply form / injectable vial, topical serum, or subcutaneous formulation Compounding pharmacy type / 503A (patient-specific) with valid prescription Typical prescription requirement / yes, a licensed provider must prescribe Why Medicare Advantage Does Not Cover GHK-Cu Medicare Advantage plans, also called Medicare Part C, bundle hospital (Part A), outpatient (Part B), and usually prescription drug (Part D) benefits into a single managed-care package

We also offer comprehensive support through in-app tracking tools and a supportive community to address both the biological and behavioral aspects of weight care
Each phase lasts a minimum of four weeks